Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | PDE7A | Q13946 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | LTA4H | P09960 | 2/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | TTR | P02766 | 1/20 | 0.51 |
| ▸ | ALB | P02768 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.49 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.49 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29467788 | 1.00 | ALDH1A1 (0.65) | ALDH1A1KMT2AMEN1MAPTPDE7A | |
| SCHEMBL238962 | 0.85 | L3MBTL1 (0.62) | ALDH1A1KMT2AMEN1MAPTL3MBTL1 | |
| SCHEMBL1283885 | 0.84 | HSPB1 (0.67) | ALDH1A1KMT2AMEN1MAPTL3MBTL1 | |
| SCHEMBL6750951 | 0.84 | L3MBTL1 (0.57) | ALDH1A1KMT2AMEN1MAPTPDE7A | |
| 2,4'-Oxybis(Nitrobenzene) SCHEMBL9474586 | 0.84 | HSPB1 (0.62) | ALDH1A1KMT2AMEN1MAPTL3MBTL1 | |
| SCHEMBL30421576 | 0.83 | PDE7A (0.53) | ALDH1A1KMT2AMEN1MAPTPDE7A | |
| SCHEMBL14375448 | 0.83 | MEN1 (0.57) | ALDH1A1KMT2AMEN1MAPTPDE7A | |
| SCHEMBL8695351 | 0.83 | L3MBTL1 (0.60) | ALDH1A1KMT2AMEN1MAPTL3MBTL1 | |
| SCHEMBL7021137 | 0.83 | L3MBTL1 (0.56) | ALDH1A1KMT2AMEN1MAPTL3MBTL1 | |
| SCHEMBL7123876 | 0.83 | L3MBTL1 (0.56) | ALDH1A1KMT2AMEN1MAPTPDE7A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11111345-B2 | Prepreg and carbon fiber-reinforced composite material | TORAY INDUSTRIES, INC. (JP) | 2021-09-07 | — | — | US | disclosed |
| EP-3800285-A1 | SIZING-AGENT-COATED CARBON FIBRE BUNDLE, CARBON-FIBRE-BUNDLE PRODUCTION METHOD, AND PREPREG | Toray Industries, Inc. (JP) | 2021-04-07 | — | — | EP | disclosed |
| US-10400076-B2 | Epoxy resin composition, prepreg, and carbon fiber-reinforced composite material | TORAY INDUSTRIES, INC. (JP) | 2019-09-03 | — | — | US | disclosed |
| US-10184034-B2 | Carbon fiber forming raw material, formed material, and carbon fiber-reinforced composite material | TORAY INDUSTRIES, INC. (JP) | 2019-01-22 | — | — | US | disclosed |
| US-10138593-B2 | Sizing agent-coated carbon fibers, process for producing sizing agent-coated carbon fibers, prepreg, and carbon fiber reinforced composite material | TORAY INDUSTRIES, INC. (JP) | 2018-11-27 | — | — | US | disclosed |
| EP-3020763-B1 | EPOXY RESIN COMPOSITION, PREPREG, AND CARBON FIBER-REINFORCED COMPOSITE MATERIAL | TORAY INDUSTRIES (JP) | 2018-08-29 | — | — | EP | disclosed |
| EP-2799616-B1 | CARBON FIBER COATED WITH SIZING AGENT, PROCESS FOR PRODUCING CARBON FIBER COATED WITH SIZING AGENT, PREPREG, AND CARBON FIBER REINFORCED COMPOSITE MATERIAL | TORAY INDUSTRIES (JP) | 2018-07-11 | — | — | EP | disclosed |
| US-9834670-B2 | Epoxy resin composition for fiber-reinforced composite material, prepreg, and fiber-reinforced composite material | TORAY INDUSTRIES, INC. (JP) | 2017-12-05 | — | — | US | disclosed |
| US-20170327657-A1 | PREPREG AND CARBON FIBER-REINFORCED COMPOSITE MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2017-11-16 | — | — | US | disclosed |
| EP-2886590-B1 | PREPREG, AND CARBON FIBER REINFORCED COMPOSITE MATERIAL | TORAY INDUSTRIES (JP) | 2017-11-08 | — | — | EP | disclosed |
| US-8415490-B2 | Epoxy compound and manufacturing method thereof | TORAY FINE CHEMICALS CO., LTD. (JP) | 2013-04-09 | — | — | US | disclosed |
| US-8263216-B2 | Epoxy resin composition for fiber-reinforced composite material, prepreg, and fiber-reinforced composite material | TORAY INDUSTRIES, INC. (JP) | 2012-09-11 | — | — | US | disclosed |
| WO-2012082436-A2 | MODULATORS OF HISTONE METHYLTRANSFERASE, AND METHODS OF USE THEREOF | Epizyme, Inc. (US) | 2012-06-21 | — | — | WO | disclosed |
| US-20120035299-A1 | EPOXY RESIN COMPOSITION FOR FIBER-REINFORCED COMPOSITE MATERIAL, PREPREG, AND FIBER-REINFORCED COMPOSITE MATERIAL | TORAY INDUSTRIES, INC. (JP) | 2012-02-09 | — | — | US | disclosed |
| EP-2341092-A1 | EPOXY COMPOUND AND MANUFACTURING METHOD THEREOF | Toray Fine Chemicals Co., Ltd. (JP) | 2011-07-06 | — | — | EP | disclosed |
| US-20110040111-A1 | EPOXY COMPOUND AND MANUFACTURING METHOD THEREOF | TORAY FINE CHEMICALS CO., LTD. (JP) | 2011-02-17 | — | — | US | disclosed |
| US-5939418-A | ANTICOAGULANT | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1999-08-17 | — | — | US | disclosed |
| EP-0874629-A4 | ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS | DU PONT MERCK PHARMA (US) | 1999-08-04 | — | — | EP | disclosed |
| EP-0874629-A1 | ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-11-04 | — | — | EP | disclosed |
| WO-1997023212-A1 | ISOXAZOLINE, ISOTHIAZOLINE AND PYRAZOLINE FACTOR Xa INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110040111-A1 | EPOXY COMPOUND AND MANUFACTURING METHOD THEREOF | CYP2E1, CYP4A11, CYP1A1 | ALDH1A1 576/4885KMT2A 541/4885MEN1 2577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.